The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder.
about
Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adultsTherapist-supported Internet cognitive behavioural therapy for anxiety disorders in adultsFear extinction as a model for translational neuroscience: ten years of progress.Affect-modulated startle: interactive influence of catechol-O-methyltransferase Val158Met genotype and childhood trauma.Generation and characterization of humanized mice carrying COMT158 Met/Val alleles.Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics.The brain-derived neurotrophic factor Val66Met polymorphism predicts response to exposure therapy in posttraumatic stress disorder.Predicting outcomes following cognitive behaviour therapy in child anxiety disorders: the influence of genetic, demographic and clinical information.Functional gene polymorphisms in the serotonin system and traumatic life events modulate the neural basis of fear acquisition and extinctionGenetic polymorphisms in monoamine systems and outcome of cognitive behavior therapy for social anxiety disorder.Stress, trauma and PTSD: translational insights into the core synaptic circuitry and its modulation.A review on experimental and clinical genetic associations studies on fear conditioning, extinction and cognitive-behavioral treatment.Catehol-o-methyltransferase gene Val158met polymorphism as a potential predictor of response to computer-assisted delivery of cognitive-behavioral therapy among cocaine-dependent individuals: Preliminary findings from a randomized controlled trialNeurotrophic gene polymorphisms and response to psychological therapy.A consideration of select pre-trauma factors as key vulnerabilities in PTSD.Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders.Non-replication of the association between 5HTTLPR and response to psychological therapy for child anxiety disordersGenome-wide association study of response to cognitive-behavioural therapy in children with anxiety disorders.Association of the catechol-O-methyltransferase val158met polymorphism and anxiety-related traits: a meta-analysisCOMT Val158Met Polymorphism and Symptom Improvement Following a Cognitively Focused Intervention for Irritable Bowel Syndrome.Therapygenetics in mindfulness-based cognitive therapy: do genes have an impact on therapy-induced change in real-life positive affective experiences?Clinical and genetic outcome determinants of Internet- and group-based cognitive behavior therapy for social anxiety disorder.Sleep Treatment Outcome Predictors (STOP) Pilot Study: a protocol for a randomised controlled trial examining predictors of change of insomnia symptoms and associated traits following cognitive-behavioural therapy for insomnia in an unselected samplMultilevel impact of the dopamine system on the emotion-potentiated startle reflex.Attention biases and habituation of attention biases are associated with 5-HTTLPR and COMTval158met.Stressful life events and catechol-O-methyl-transferase (COMT) gene in bipolar disorder.5HTT is associated with the phenotype psychological flexibility: results from a randomized clinical trial.
P2860
Q24186033-52DEB6A6-2456-4F39-9059-1016639521FBQ24187393-E246EAC9-0953-4EE6-BFF5-D92E05A42B6DQ28254365-06D06379-1834-492D-9F8C-E99991822A40Q28728111-53B68CB7-1486-4E6D-8EBE-27DE83AC5C3AQ30407994-54D0D22F-56CE-4FAA-8AB7-982C8E703AD4Q31114020-D68EECDF-8A89-42F8-B6A2-1872D241177AQ34288971-1FAE91EB-B3FC-4309-9819-FDC549CF9ECCQ34351334-CFE4C92D-D0C3-47C8-8201-477881FDFD14Q34408119-38EF723E-8D1F-44CA-9D25-59A642F5A896Q35048160-E0E4F262-89F9-4E0D-AB87-1C5745EF67FFQ35634398-ACBDF7A6-C508-4145-BB4F-662A1E0C9AFFQ35844099-8A957E02-804F-4EEF-BE1C-2FE243ECE2D4Q35893529-2FA49F2D-1D2C-4094-AA69-74970B8E319FQ36001550-71D3F0EB-78D6-4EFF-A12B-9EC270CDEC0FQ36239244-71CEE327-E894-4833-8883-72BCECC3C6C0Q36618462-F20123DF-9290-48E9-A256-D66025FD36D4Q36814908-BF9142E5-C860-4AEE-8A49-5F9DD5BDCCCCQ37223300-CF12AEB0-11D3-4247-8E4A-B171773021D6Q37710195-945C621A-A0B5-4FED-8F3F-74BAF019464BQ38751559-158FDCB8-5BDC-4A83-A7BE-EE909806E2DFQ39264351-37FE72AC-2CC0-4C95-A3B8-5A74C17DC858Q43612210-D74E34C9-72B2-4AE6-8011-0C8F6FE636D1Q47094265-226AA23D-33C0-4609-83EB-48D7F55629E2Q47772329-1B4D8577-AB85-490C-BA38-BFAAA0FC8F92Q47782653-2A83DB89-36D6-46A4-932E-67CB82A02B17Q47990255-DA557FDC-B8AE-4D16-AAEF-74F35E6C5457Q53638094-9B7EB506-4555-4A02-9670-B08C126BFC06
P2860
The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The COMTval158met polymorphism ...... l treatment in panic disorder.
@ast
The COMTval158met polymorphism ...... l treatment in panic disorder.
@en
type
label
The COMTval158met polymorphism ...... l treatment in panic disorder.
@ast
The COMTval158met polymorphism ...... l treatment in panic disorder.
@en
prefLabel
The COMTval158met polymorphism ...... l treatment in panic disorder.
@ast
The COMTval158met polymorphism ...... l treatment in panic disorder.
@en
P2093
P2860
P50
P356
P1433
P1476
The COMTval158met polymorphism ...... l treatment in panic disorder.
@en
P2093
Arne Ohman
Jan Bergström
Martin Schalling
Nils Lindefors
P2860
P2888
P356
10.1186/1471-244X-10-99
P577
2010-11-26T00:00:00Z
P6179
1042442634